Lung Cancer Screening: High Hopes, Hard Realities - How to Move Forward
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Jeffrey Velotta, MD FACS
Cherie Erkmen, MD
Presentations
- Lung Cancer Screening: Hurdles, Handiwork, and the Horizon
Douglas Wood, MD, FACS, FRCSEd
- Starting a Lung Cancer Screening Program
Andrea McKee, MD
- The Impact of Removing the 15-year Since Quitting Smoking Criterion on Lung Cancer Screening Eligibility
Alexandra Potter, BS
- Expanded Patient Populations and Reducing Disparities in Lung Cancer Screening
Dan J. Raz, MD MAS
Disclosure(s): Astra Zeneca: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Genentech: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 17, 2023)
- Community awareness of lung cancer screening: a cross-sectional survey
Lauren Ryan
- Lung Cancer Screening Community Outreach
Chi-Fu Yang, MD
Disclosure(s): Astrazeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 29, 2023)
- Association between type of insurance coverage and rates of early-stage lung cancer diagnosis: VA hospitals outperform other insurance models
Nikki E. Rossetti, MD, MS
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation
Price
Cost:
$0.00
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Jeffrey Velotta, MD FACS
Cherie Erkmen, MD
Presentations
- Lung Cancer Screening: Hurdles, Handiwork, and the Horizon
Douglas Wood, MD, FACS, FRCSEd
- Starting a Lung Cancer Screening Program
Andrea McKee, MD
- The Impact of Removing the 15-year Since Quitting Smoking Criterion on Lung Cancer Screening Eligibility
Alexandra Potter, BS
- Expanded Patient Populations and Reducing Disparities in Lung Cancer Screening
Dan J. Raz, MD MAS
Disclosure(s): Astra Zeneca: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Genentech: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 17, 2023)
- Community awareness of lung cancer screening: a cross-sectional survey
Lauren Ryan
- Lung Cancer Screening Community Outreach
Chi-Fu Yang, MD
Disclosure(s): Astrazeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 29, 2023)
- Association between type of insurance coverage and rates of early-stage lung cancer diagnosis: VA hospitals outperform other insurance models
Nikki E. Rossetti, MD, MS